Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

21.13
Delayed Data
As of 3:59pm ET
 +0.77 / +3.78%
Today’s Change
11.60
Today|||52-Week Range
24.57
+11.62%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close20.36
Today’s open20.42
Day’s range20.26 - 21.32
Volume619,765
Average volume (3 months)408,848
Market cap$768.2M
Dividend yield--
Data as of 3:59pm ET, 02/27/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-137.92%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+254.19%
P/E ratioNM
Price/Sales7.26
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+0.80+3.43%
CRSPCRISPR Therapeutics ...+2.05+11.45%
EPZMEpizyme Inc+1.50+12.35%
ANIPANI Pharmaceuticals ...+0.98+1.66%
Data as of 3:59pm ET, 02/27/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$99.9M
Annual profit (last year)$117.2M
Net profit margin117.36%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs